在与儿童死亡有未经证实的联系之后,林业发展局审查更严格的疫苗规则;疾病防治中心建议为幼儿提供医生咨询。 FDA reviews stricter vaccine rules after unconfirmed link to child deaths; CDC advises doctor consultations for young children.

据报道,FDA正在考虑在内部审查后,加强疫苗批准标准,该审查报告显示10名儿童死亡与COVID-19疫苗有关,尽管该机构尚未确认因果关系. The FDA is considering stricter vaccine approval standards following an internal review that reportedly links 10 child deaths to COVID-19 vaccines, though the agency has not confirmed causation. 根据VAERS数据的研究结果, FDA高官Vinay Prasad在一份备忘录中引用了这些数据, 表明心肌炎可能是导致因素, 但专家指出这些数据尚未经过同行评审. The findings, based on data from VAERS and cited in a memo by top FDA official Vinay Prasad, suggest myocarditis may be a contributing factor, but experts note the data has not been peer-reviewed. FDA专员Marty Makary表示, 该机构不再批准“灌木印章”, 并质疑每年MRNA对儿童开枪的科学依据。 FDA Commissioner Marty Makary said the agency would no longer "rubber-stamp" approvals and questioned the scientific basis for annual mRNA shots in children. 作为回应,疾病防治中心现在建议,在为6岁以下儿童接种疫苗之前先进行医生咨询。 In response, the CDC now recommends doctor consultations before vaccinating children under 6. 公共卫生官员强调疫苗的总体安全性和效益,强调目前的批准程序依然健全。 Public health officials emphasize the vaccines' overall safety and benefits, stressing that the current approval process remains robust.